Variability in morphology and cell proliferation in sequential biopsies of mantle cell lymphoma at diagnosis and relapse: clinical correlation and insights into disease progression
Authors:
- 13 December 2012
- journal article
- Published by Wiley in Histopathology
- Vol. 62 (2) , 334-342
Abstract
Aims: The variable morphology of mantle cell lymphoma (MCL) is assumed to reflect progression from an early form with classical cytology and mantle zone or nodular growth to a later, more aggressive variant of the disease with blastoid cytology and a diffuse growth pattern. However, studies of sequential biopsies of MCL are very limited, and we therefore undertook to carry out such a study.Methods and results: We analysed a cohort of 47 MCLs at primary diagnosis and relapse for cytology, growth pattern, and Ki67 index, and correlated the findings with outcome. In the majority of cases, the mantle zone growth pattern was lost, but it had been reacquired in a small subset of MCLs at relapse. Twenty‐two per cent of MCLs with classical/small cell cytology acquired blastoid features during the course of the disease. However, 50% of MCLs with blastoid cytology at primary diagnosis recurred as a classical variant. The Ki67 index increased over time, and was associated with prognosis in the primary and the relapse biopsy specimens.Conclusions: This is the first study to show, in a large cohort of MCLs, that the Ki67 index increases over time in MCL. Assessment of the Ki67 index remains a useful prognostic tool if assessment is performed in the relapse situation.Keywords
This publication has 19 references indexed in Scilit:
- In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behaviorHaematologica, 2011
- Histopathology of Mantle Cell LymphomaSeminars in Hematology, 2011
- Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup studyBlood, 2010
- Ki-67 as a prognostic marker in mantle cell lymphoma—consensus guidelines of the pathology panel of the European MCL NetworkJournal of Hematopathology, 2009
- Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeuticsNature Reviews Cancer, 2007
- Characterization of genetic changes in MCL by interphase FISH on tissue sectionsLeukemia & Lymphoma, 2007
- The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphomaBlood, 2006
- Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profilingBlood, 2005
- Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL NetworkBritish Journal of Haematology, 2005
- Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual diseaseEuropean Journal of Haematology, 2005